Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CAPRICOR THERAPEUTICS INC.

Capricor Therapeutics Inc. (NASDAQ: CAPR)
Listen to this Section


$26.86
-1.0900 ( -3.90% ) 247.4K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Clinical Trial Pipeline Stages


Drug Name Stage
CAP-1002DetailsCOVID-19 Failed

Market Data


Open $26.86
Previous Close $27.95
Volume 247.4K
Market Cap $1.60B
Day Range $26.84 - $28.19
52 Week Range $4.30 - $40.37
Shares Outstanding 57.91M
Change % -3.90%
Net Change ▼ -1.0900
Insider Ownership 0.24%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2002
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 1,783,668.00

Date Type Amount Purchased Purchaser
2024-01-04 Sale -29250.00 DUNBAR GEORGE W JR
2024-01-04 Sale -29250.00 COLLIER EARL M JR
2024-01-04 Sale -200000.00 Litvack Frank
2024-01-04 Sale -80000.00 Krasney Karen
2024-01-04 Sale -85000.00 Bergmann Anthony
2023-10-24 Sale -2178.00 Bergmann Anthony
2023-10-13 Buy 410.00 Musket David B
2023-10-12 Buy 10000.00 COLLIER EARL M JR
2023-10-11 Buy 5083.00 Musket David B
2023-10-10 Buy 5000.00 Auwaerter Paul Gisbert

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Apr 03, 2026
4 Insider transactions 1 Apr 01, 2026
4 Insider transactions 1 Apr 01, 2026
4 Insider transactions 1 Apr 01, 2026
pre Proxies and info statements 19 Mar 31, 2026
4 Insider transactions 1 Mar 27, 2026
10-k Annual reports 91 Mar 17, 2026
8-k 8K-related 14 Mar 12, 2026
8-k 8K-related 14 Mar 10, 2026
schedule Other 3 Feb 26, 2026

Latest News


× Before browsing our site, please accept our cookies policy